FMC Corp (FMC) Stock Price Today
Broadcom shares dip under $400, seen as a buying opportunity amid strong AI-driven growth and solid dividends.
Broadcom's stock recently dropped below $400, prompting investors to buy amid its strong position in AI semiconductor and networking markets. The company reported Q2 FY2026 revenue of $22.19 billion, with AI semiconductor revenue up 143% year-over-ye...
Broadcom's AI growth boosts revenue but pressures margins, causing mixed stock performance.
Broadcom's revenue grew 32% driven by AI semiconductor sales hitting $10.8 billion last quarter, expected to rise to $16 billion next quarter. Despite strong operating margins, the market remains cautious as AI chips have lower profitability, potenti...
NYSE American extends Mynd.ai's compliance deadline to Dec 2027, allowing continued listing amid financial recovery efforts.
Mynd.ai has received approval from NYSE Regulation for its compliance plan, granting an extension until December 2, 2027, to meet NYSE American listing standards. This allows Mynd.ai to maintain its stock listing while it works on strengthening its f...
Uber partners with Zipline to launch drone deliveries on Uber Eats, aiming for 1 million daily by 2029
Uber is investing in and partnering with drone delivery startup Zipline to enable drone deliveries on Uber Eats, starting by the end of 2024 in Zipline's current markets. The goal is to reach one million deliveries per day using Zipline's drones by 2...
Iran rejects extension of U.S. MoU, crude oil prices rise amid rising tensions
The memorandum of understanding (MoU) between the U.S. and Iran, signed on June 17 to keep the Strait of Hormuz open during nuclear talks, expired Monday without extension. Iran's Foreign Ministry ruled out further talks to extend the MoU, accusing t...
Galmed's Aramchol boosts prostate cancer drug Xtandi's effectiveness in preclinical study, promising better treatment.
Galmed Pharmaceuticals announced preclinical results showing that combining Aramchol with Xtandi (enzalutamide) increased prostate cancer cell death by 3-4 times compared to Xtandi alone. Xtandi, a major prostate cancer drug with global sales of $8 b...
Gunnison Copper advances 2026 drilling with expanded metallurgical testing in Arizona project
Gunnison Copper Corp has completed its planned metallurgical drilling at the Gunnison deposit in Arizona and expanded its testing program as part of its 2026 district-wide drilling campaign. The company is currently operating two drill rigs and plans...
ReconAfrica flows gas from second Huttenberg zone, preps for horizontal test at Kavango West 1X well
ReconAfrica Energy Africa has successfully flowed natural gas and potential liquids from the second Huttenberg zone at its Kavango West 1X well, completing vertical testing and preparing for a horizontal open-hole test. The flow occurred immediately ...
Attovia Therapeutics debuts with a novel antibody platform targeting chronic itch cytokine IL-31.
Attovia Therapeutics recently went public with a market cap of about $288 million, focusing on its Attobody platform that creates biparatopic antibodies. Its lead drug, ATTO-1310, targets IL-31, a cytokine linked to chronic itch and atopic dermatitis...
Canaan mined 46 bitcoins in July, boosting its crypto treasury and authorizing share buybacks using digital assets.
In July 2026, Canaan Inc. mined 46 bitcoins, increasing its cryptocurrency holdings to 1,917 BTC and 3,952 ETH. The company maintained strong mining efficiency and steadily recovered joint venture operations after wildfire disruptions. Canaan also au...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.